European Journal of Molecular Pharmacy

Developing Research at the Intersection of Molecules and Medicine

The European Journal of Molecular Pharmacy (EJMP) is a peer-reviewed, international and openly-accessible journal focused on the publication of high-quality research in the area that uniforms molecular science and pharmaceutical innovation. We offer a reliable platform to scientists, researchers, and professionals to post work which enhances learning, inspires discovery, and yields better therapeutic results. EJMP stimulates studies that determine the applicability of molecular principles in designing drugs, delivery and effectiveness in clinical trials. The journal is concerned with the articles that would have a significant impact on pharmaceutical science and molecular pharmacology whether it is in the field of laboratory based finding, method development, or translational research.

Relating Molecular Insight to Pharmaceutical Advancement

In pharmacy and medicine, we at EJMP support research that connects functional and practical research. The following studies have been accepted into the journal:

• Explore relevant drug-action and drug-response molecular mechanisms.
• Design new drug delivery agents and preparations.
• Learn about pharmacodynamics and pharmacokinetics as well as therapeutic optimization.
• Translational basic molecular science to clinical/preclinical knowledge.
• Would make pharmaceutical solutions safer and more effective.

Areas of Interest

Original research papers and significant review articles covering a broad range of topics are produced by EJMP, including (but not limited to):

• Drug mechanisms and molecular pharmacology.
• Pharmaceutical biotechnology and biopharmaceutics.
• Nano- and targeted drug delivery.
• Medicinal chemistry and molecular design.
• Pharmacogenomics and individual therapy.
• Excipient innovation, formulation science and drug stability.

Additionally, multidisciplinary contributions that link molecular discoveries to novel pharmacological technologies and clinical significance will be gladly accepted.

Strict Peer Review and Ethics

All submitted manuscripts to the EJMP are submitted to an orderly peer-review of qualified, educated reviewers that possess expertise in each manuscript's respective area of discipline or field. The peer-review process provides an opportunity to determine whether the submission meets accepted academic standards with respect to quality, originality, and scientific integrity prior to publication. EJMP adheres to transparent editorial practices and ethical standards, is committed to maintaining the trust and credibility of scholarly communication through its publishing process.

Open Access for Global Reach

EJMP is based on a complete open-access framework, allowing all the published research to be free to the readers across the world. This model encourages the wide spread dissemination, support international collaboration and allows researchers, clinicians and industry professionals free and unfettered access to published findings and utilize them without restriction.

In Favor of Scientific Advancement

The European Journal of Molecular Pharmacy also strives to become one of the top sources of molecular and pharmaceutical research, to help in innovating and developing a knowledge that can guide the scientific world as well as practice. The journal, combining a variety of worthwhile opinions and research on the topic, leads to the progress of scientific knowledge in the field of drugs, healthcare, and treatment. .